How to Buy Novartis Ag Stock
Novartis Ag
Novartis Ag is a general drug manufacturer company located in Switzerland, which is part of the Healthcare sector, and is traded under the ticker NVS on the NYSE exchange.
Novartis Ag stock last closed at $110.86, up 1.17% from the previous day, and has increased 19.1% in one year. It has overperformed other stocks in the Drug Manufacturers - General industry by 0.19 percentage points. Novartis Ag stock is currently +17.04% from its 52-week low of $94.72, and -8.32% from its 52-week high of $120.92.
There are currently 1.98B NVS shares outstanding. The market value of NVS is $218.96B. In the last 24 hours, 1.58M NVS shares were traded.
How to Buy Novartis Ag Stock
Wondering how to invest in Novartis Ag stock? Here's how.
- Figure out where to buy Novartis Ag stock: You need to decide on an online brokerage, but don't worry - we've analyzed dozens of stock brokerages and apps to help you decide where to buy Novartis Ag stock.
- Sign up for your brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've selected.
- Deposit funds into your brokerage account: Select your method of payment and add your details.
- Research Novartis Ag stock: The Novartis Ag ticker symbol is NVS. Is Novartis Ag stock a good investment? Should you buy shares of NVS? How do NVS's underlying business fundamentals look? Do top analysts think Novartis Ag is a good buy? Why has NVS's stock price moved recently? (Hint: Our stock market analysis tools can help you evaluate if NVS is a good stock to buy).
- Execute your NVS trade: Decide if you will purchase NVS shares at the current market price or use a limit order to purchase NVS shares at a specific price.
- Keep an eye on your NVS investment: Create a watchlist to important notifications about your new investment in Novartis Ag stock.
Step 1: Figure out where to buy Novartis Ag stock
You need a brokerage account in order to access the NYSE market and buy NVS stock.
Our recommended brokerage: eToro
Based on our experience, eToro is the best place to buy stocks. Here's why:
- Invest in stocks with zero commissions: Invest without commissions.
- Buy fractional shares: Even if you don't have the money to buy a full share, you can still buy the stock.
- Access to world markets: From Tech to Healthcare, New York to Shanghai (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's leading stock exchanges.
- Social investing: eToro has a community with more than 20 million users worldwide. Talk to, learn from, and copy the crypto trades of other investors.
- Security: eToro is a regulated and licensed fintech leader.
- Buy other assets: Such as ETFs and cryptocurrencies.
Get $10 towards your share purchase by opening an account with eToro today. This offer is only for US users.
Open eToro AccountStep 2: Sign up for your brokerage account
Now that you've picked the best brokerage, it's time to fill out some personal info so you can invest in NVS today.
How to Start a New Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Input your personal data to create a new trading account.
- Send your details by pressing the "Create Account" button. Get started with eToro today
Step 3: Deposit funds into your brokerage account
Now that you've filled out your info on investing apps, you need to deposit funds:
Check out this video walkthrough for more details transferring money into your new investment account.
Step 4: Research Novartis Ag stock
After you have selected the best place to buy Novartis Ag stock, it's critical to research their stock prior to investing, so you truly wrap your head around the risk and upside.
Novartis Ag Numbers
Novartis Ag Due Diligence Score
WallStreetZen was created to help average investors perform better fundamental analysis quickly.
You can view all of the due diligence checks on NVS's stock page.
How is NVS stock valued?
Analysts use many financial metrics, analyses, models, and charts to gauge NVS's intrinsic value.
Using relative valuations ratios:
- NVS may be undervalued based on its P/E ratio of 18.73x, relative to Drug Manufacturers - General industry P/E ratio of 52.36x
- NVS could be undervalued based on its P/B ratio of 4.97x, relative to Drug Manufacturers - General industry P/B ratio of 6.01x
- NVS could be overvalued based on its PEG ratio of 1.17x
You can access more valuation analysis on NVS's stock here.
A quick look at NVS Financials
Signs that NVS is financially healthy:
- There are more short-term assets than short-term liabilities on the NVS balance sheet.
- NVS earnings of $14.65B is not sufficient to cover its interest payments.
- NVS's operating cash flow of $17.62B allows it to safely service it's debt of $31.40B.
- There are more short-term assets than long-term liabilities on the NVS balance sheet.
Signs that NVS is not financially healthy:
- NVS profit margin has gone down from 31.8% to 23.1% in the past year.
- NVS has a relatively high debt to equity ratio of 1.32.
- Total NVS debt is higher than 5 years ago, relative to shareholder equity.
Is it a good time to buy Novartis Ag stock, according to Wall Street analysts?
Out of 1 Equities analysts who monitor NVS, the consensus analyst rating on Novartis Ag is a Hold
Please keep in mind that analyst forecasts are not recommendations, nor are they financial advice.
You can dive deeper into what analysts are forecasting on the Novartis Ag stock forecast page.
NVS Technicals
NVS Growth Numbers
Last year, NVS earnings were $11.94B. During the past five year, NVS's earnings have grown by 2.95% per year. This was faster than the Drug Manufacturers - General industry average of 0.91%.
Last year, NVS revenue was $51.72B. Over the past 5 year, NVS's revenue has increased by 1.22% per year. This was slower than the Drug Manufacturers - General industry average of 9.2%.
You can research NVS's earnings and revenue performance here.
What are NVS insiders up to?
Over the last year, executives and large shareholders at NVS have not bought or sold any shares.
Learn more about who owns NVS shares here.
Does NVS provide a stable income stream?
Novartis Ag pays a dividend of 3.49%, compared to the Drug Manufacturers - General industry's average dividend yield of 3.4%. If you owned $1,000 of NVS stock, you would have received $34.90 in the past year.
Novartis Ag dividend payments have consistently grown over the past decade but have not remained stable.
Dig into more analysis about Novartis Ag dividend yield and history here.
What do other traders have to say about NVS?
One of the major reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to learn what other traders have to say.
Step 5: Execute your NVS trade
You have two primary types of orders:
- Market order: A market order is an order to buy or sell a stock at the best price on the market.
Market orders are mostly fine for most investors. - Limit order: A limit order is an order to buy or sell a stock at a specific price (or better).
If you want to be sure you're buying or selling at a particular dollar amount limit, place a limit order.
Press the Open button and eToro will place the order.
If you need more assistance buying stocks on eToro, watch the helpful video below:
Step 6: Keep an eye on your NVS investment
Now that you own some NVS shares, you'll want to keep up with your new investment.
Put NVS on a watchlist to track the latest developments regarding your NVS stock.
NVS Feed
How to Buy Stock in Novartis Ag
To summarize, here are the 6 steps to buy stock in Novartis Ag:
- Figure out where to buy Novartis Ag stock
- Sign up for your brokerage account
- Deposit funds into your brokerage account
- Research Novartis Ag stock
- Execute your NVS trade
- Keep an eye on your NVS investment
If you need a place to buy stocks, eToro is our recommended option.
Get Started with eToro TodayIf you would like to keep an eye on your new investment in Novartis Ag, add NVS to your watchlist below.
Other "How To" Guides You Might Like
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.